Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Malaysian Medtech Agency Introduces New Fee To Tackle Surge In Product Classification Enquiries

Executive Summary

The Malaysian medtech regulator says an increase in product classification-related enquiries is causing a drain on its resources and the service should be supported by a fee.

You may also be interested in...



Malaysia's New Medtech Regulatory System Imminent - And No More Extension This Time

Malaysia's conformity assessment-based system for medical devices will finally come into effect at midnight on June 30 2016. That is less than two weeks away, and 'there will be no extension,' says Sasikala Devi Thangavelu, director of the policy, code and standard division of the Malaysian Medical Device Authority1.

Malaysia Exempts Low-Risk Devices From Conformity Assessment, But Registration Mandatory

The Malaysian government exempted all types of Class A (lowest-risk) devices from conformity assessment requirements as of April 18 to make it easier for companies to bring such products to the market1. These devices, however, will have to continue complying with other regulatory requirements such as labelling and post-marketing commitments.

Singapore Develops Online Tool To Assist Risk-Based Classification Of Devices, IVDs

Singapore's Health Sciences Authority has launched a new online tool to help medical device and IVD sponsors to identify the correct risk classification for their products1.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT103750

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel